TABLE 1.
MOUSE MODELS AND HUMAN DISEASE CORRELATES
| Mouse Model Abbreviation | Murine Strain and Mutation | Human Disease Correlate | Human: Pulmonary Phenotype | Human Disease: Other Clinical Features | Protein | Rationale for Study |
| Wild-type (WT) | C57BL/6J | n/a | n/a | n/a | n/a | Wild-type control |
| WT(GFP) | C57BL/6J ubiquitously expressing GFP (ubiquitin C promoter) | n/a | n/a | n/a | GFP+ | Wild-type control for bone marrow transplant experiments |
| HPS1mt | HPS1 mutations; Naturally occurring (“pale ear” mouse) | HPS-1 | Pulmonary fibrosis | Albinism, bleeding, colitis | Novel, BLOC3 | Correlate for HPS human genotype most commonly associated with fibrosis |
| HPS2mt | HPS2 mutations: Naturally occurring inversion-duplication in AP3b1 (“pearl” mouse) | HPS-2 | Pulmonary fibrosis | Albinism, bleeding, neutropenia | Adaptor protein AP-3 | Correlate for HPS human genotype associated with pulmonary fibrosis; AP-3 most amenable to study |
| HPS2ko | Targeted knock-out of HPS2 (34) | HPS-2 | Pulmonary fibrosis | Albinism, bleeding, neutropenia, HLH | Adaptor protein AP-3 | Comparison with HPS2mt, particularly with transgenic correction |
| HPS3mt | HPS3 mutations; Naturally occurring (“cocoa” mouse) | HPS-3 | No pulmonary fibrosis | Albinism, bleeding, colitis | Novel, BLOC2 | Correlate for HPS human disease not associated with fibrosis |
| CHSmt | Lyst/J mutations Naturally occurring (“beige” mouse) | CHS | No pulmonary fibrosis | Recurrent infections | Lyst | Other disease control, not associated with fibrosis |
| HPS2:TG+ | HPS2mt or HPS2ko with transgenic correction of AP3b1 in the lung epithelium | n/a | n/a | n/a | Adaptor protein AP-3 | Transgenic model developed |
Definition of abbreviations: AP-3 = adaptor protein 3; BLOC = biogenesis of lysosomal organelle complex; CHS = Chediak-Higashi syndrome; GFP = green fluorescent protein; HLH = hemophagocytic lymphohistiocytosis; HPS = Hermansky-Pudlak syndrome; ko = knock-out; mt = mutant; n/a = not applicable.